Abstract
Thyrotoxic Periodic Paralysis (TPP) is a rare diagnosis in the western world; however, its incidence has been rising in recent years due to globalization. This condition has the potential to be deadly if not detected and treated in a time appropriate manner. This case discusses our management of a patient who came into our hospital with complaints of total body numbness and weakness for several hours. He was subsequently diagnosed with TPP and was treated with Methimazole and aggressive potassium supplementation and had an overall good outcome. This case report highlights an unusual disease that needs to be considered as a differential when a young man reports numbness and weakness to the clinician.
Highlights
Thyrotoxic Periodic Paralysis (TPP) is a rare diagnosis in the western world; its incidence has been rising in recent years due to globalization
Thyrotoxic periodic paralysis (TPP) is a disease categorized as weakness and paralysis due to hypokalemia in the setting of hyperthyroidism
Thyrotoxic Periodic Paralysis is a rare disease that was first documented by Dr Rosenfeld back in 1902
Summary
Thyrotoxic periodic paralysis (TPP) is a disease categorized as weakness and paralysis due to hypokalemia in the setting of hyperthyroidism. Thyrotoxic Periodic Paralysis (TPP) is a rare diagnosis in the western world; its incidence has been rising in recent years due to globalization. He was subsequently diagnosed with TPP and was treated with Methimazole and aggressive potassium supplementation and had an overall good outcome. TPP is rarely seen in North America, with an incidence of 1/100,000 [1], and it affects only 1%-2% of thyrotoxic patients in the United States.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Critical Care and Emergency Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
